Dopamine receptors and sleep induction in man
- PMID: 448384
- PMCID: PMC490233
- DOI: 10.1136/jnnp.42.5.458
Dopamine receptors and sleep induction in man
Abstract
Sleep induction has been studied in humans after the administration of apomorphine, a direct stimulant of the central dopaminergic system. The drug induced sleep and vomiting in healthy volunteers while it had no significant effect on 10 Parkinsonism patients treated for a long period with L-dopa. Apomorphine given to a group of Parkinsonism patients not receiving any specific treatment, and with a lower degree of disease severity, induced vomiting and sleep with a pattern similar to that in healthy subjects. A relationship between the dopaminergic system and sleep induction is suggested.
Similar articles
-
The short-duration response to apomorphine: implications for the mechanism of dopaminergic effects in parkinsonism.Ann Neurol. 1990 Jun;27(6):660-5. doi: 10.1002/ana.410270613. Ann Neurol. 1990. PMID: 2360803
-
Diurnal responsiveness to apomorphine.Neurology. 1987 Jul;37(7):1250-3. doi: 10.1212/wnl.37.7.1250. Neurology. 1987. PMID: 3601094
-
Receptor basis for dopaminergic supersensitivity in Parkinson's disease.Nature. 1978 May 4;273(5657):59-61. doi: 10.1038/273059a0. Nature. 1978. PMID: 692671 No abstract available.
-
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.Biomedicine. 1979 Jun;30(2):67-71. Biomedicine. 1979. PMID: 383169 Review.
-
[Apomorphine in off state--clinical experience].Neurol Neurochir Pol. 2007 Mar-Apr;41(2 Suppl 1):S40-8. Neurol Neurochir Pol. 2007. PMID: 17941458 Review. Polish.
Cited by
-
'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?Drug Saf. 2002;25(7):473-83. doi: 10.2165/00002018-200225070-00001. Drug Saf. 2002. PMID: 12093305 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources